Imunon CFO Jeffrey Church to retire; Josh Blacher appointed interim CFO effective July 1, 2026

Imunon, Inc.

Jeffrey Church retires as interim CFO effective July 1, 2026; will continue as consultant at $10,000/month retainer.
Josh Blacher appointed interim CFO via Danforth Health, Inc. at $475/hour; serves as principal financial and accounting officer.
Blacher, 54, has served as CFO for several life sciences companies including BullFrog AI, Inmed, Therapix, and Galmed.
Church's departure is due to retirement and without any disagreements with management.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.